01 February 2006
Risk of blood splashes to masks and goggles during cesarean section.
Aderemi Olabisi Aisien, Innocent Achanya otobo UjahMed Sci Monit 2006; 12(2): CR94-97 :: ID: 445245
Abstract
Introduction: The study arose out of concern about the transmission ofinfectious diseases through mucocutaneous contact with blood and body fluids. The purpose was to identifythe risk of blood splashes to masks and goggles during cesarean section. Material/Methods: The prospectivestudy spanned 6 months between January and June 1998 to determine the incidence of blood splashes tothe masks and goggles of surgeons, assistants, and scrub nurses. All the doctors and scrub nurses whoparticipated in surgery were requested to wear masks and goggles for all the cesarean section cases duringthe study period. At the end of surgery, the surgeon examined all the masks and goggles for obvious bloodsplashes and documented these in a data sheet. Results: There were 144 cases of cesarean section performedduring the period, of which 13.2% (19) were elective and 86.8% (125) were emergencies. 74.3% (107) ofthe patients registered for antenatal care and delivered in the institution, while 25.7% (37) cases werenot booked but admitted for delivery. The mean age of the parturient and parity were 27.4+/-2.8 yearsand 5.8+/-2.4, respectively. The rate of blood splashes was 62.5% on the surgeons' masks, 63.2% on surgeons'goggles, 35.4% on assistants' masks, 38.9% on assistants' goggles, 11.1% on scrub nurses' masks, and16.0% on scrub nurses' goggles. Conclusions: We therefore recommend the use of masks and protective eyewear as part of routine surgical attire to avoid body fluid contamination that can result in acquiringinfectious diseases.
Keywords: Blood - microbiology, Cesarean Section - adverse effects, Communicable Diseases - transmission, Eye Protective Devices, Infectious Disease Transmission, Patient-to-Professional, Masks, Nigeria, Occupational Exposure - prevention & control, Operating Rooms, Pregnancy, Prospective Studies, Risk Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952